Betimol

   
Google
 
Web NewDrugInformation.com

Betimol


Drug - Betimol
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Timolol
Multiple ingredients are in alphabetical order.

Strength - EQ 0.5% BASE
The potency of the active ingredient(s), Timolol. May repeat for multiple part products.

Applicant - SANTEN OY
The firm name holding legal responsibility for Betimol. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020439
The FDA assigned number to Betimol. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Betimol. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 31, 1995
The date Betimol was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Betimol. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Betimol is in. Format is RX, OTC, DISCN.

Applicant Full Name - Santen Oy
The full name of the firm holding legal responsibility for the new application of Betimol.

Betimol